Verily
An Alphabet precision health company combining data science, AI and clinical expertise to make health information useful across research, care and public health.
Verily is an Alphabet precision health company founded in 2015 and headquartered in Dallas, Texas. It combines data science, clinical expertise and advanced technology to make health information usable, working across healthcare, life sciences, clinical research and public health. The company was launched from Google X and retains an engineering-heavy, interdisciplinary structure spanning clinicians, informaticists, engineers, data scientists and regulatory experts.
For technical staff, the core platform is Pre, an AI-native system supporting research, patient care and data-driven decision making across the healthcare ecosystem. Verily's technical domains include artificial intelligence and machine learning, health informatics, clinical research technology, biometric and device data analytics, virtual care and precision health. Data assets are substantial: health data registries of more than 750,000 consented participants, virtual care services covering over 50,000 patients, public health pathogen tracking across hundreds of US sites, and clinical trials integrated into 63 health systems.
The work is applied to real clinical and research settings. Partners include NIH's All of Us Research Program, The Michael J. Fox Foundation and leading health systems. Emphasis is placed on building trustworthy AI solutions for healthcare, with collaboration across clinical, technical and regulatory disciplines.
Verily operates from locations in Dallas, California, Boston, Massachusetts, Raleigh, North Carolina and Waterloo, Ontario, in addition to its broader United States presence.